scholarly journals Detection of Cryptococcus neoformans capsular polysaccharide antigen in asymptomatic HIV-infected patients

1995 ◽  
Vol 37 (5) ◽  
pp. 385-389 ◽  
Author(s):  
R. Negroni ◽  
C. Cendoya ◽  
A.I. Arechavala ◽  
A.M. Robles ◽  
M. Bianchi ◽  
...  

Serum samples from 242 HIV-positive persons were studied for the detection of capsular polysaccha-ride antigen of Cryptococcus neoformans; 193 of these patients presented less than 300 CD4+ cells/µl of blood and 49 patients had more than 300 CD4+ cells/µl. None of them had symptoms or signs characteristic of cryptococcosis. The capsular antigen of C. neofarmans was detected by latex agglutination technique with pronase pre-treatment (IMMY, Crypto-Latex Antigen Detection System, Immunomycologics Inc., OK, USA); in 61% of the samples, ELISA technique was also used (Premier, Cryptococcal Antigen, Meridian Diagnostic Inc., Cincinatti, Oh, USA). The comparative study of both methods showed that the results obtained were similar in 96.9% of the cases. The capsular antigen was detected in 13 out of 193 (6.7%) patients with less than 300 CD4+ cells/µl. Cryptococcosis was confirmed mycologically in 3 of these 13 cases (23%) by the isolation of C. neoformans in CSF or blood cultures. Three patients, who had presented negative results of both tests for capsular antigen, suffered disseminated cryptococcosis 4 to 8 months later. The predictive diagnostic value of capsular antigen detection of C. neoformans seems tobe low and we believe that it should not be done routinely in asymptomatic HIV-positive persons.

2004 ◽  
Vol 72 (6) ◽  
pp. 3674-3679 ◽  
Author(s):  
Luis R. Martinez ◽  
Dariush Moussai ◽  
Arturo Casadevall

ABSTRACT Cryptococcus neoformans releases capsular polysaccharide in the supernatant of liquid cultures and in tissues. Significantly less glucuronoxylomannan (GXM) was released by C. neoformans in the presence of capsule-binding monoclonal antibody (MAb). MAb-mediated inhibition of GXM release may be another mechanism by which humoral immunity can mediate protection against this pathogen.


2008 ◽  
Vol 28 (7) ◽  
pp. 341-344 ◽  
Author(s):  
Camile Lugarini ◽  
Larissa A.Z. Condas ◽  
Grazielle C.G. Soresini ◽  
Renata C.F. Santos ◽  
Marisol D. Muro ◽  
...  

Cryptococcus neoformans and C. gattii are associated with dry bird excreta but rarely recovered from birds' digestive tract. The objective of the present study was (1) to verify the existence of C. neoformans and C. gattii in crop and cloaca of wildlife and captivity birds hypothesizing about a possible primary source of this yeast in the excreta, and (2) to determine the fungi's invasive capability in avian species through latex agglutination. For that purpose, 172 cloacal and 77 crop samples of domestic pigeon, Passerine, and Psittacine birds were collected. None of these samples was positive, suggesting that the yeast is not saprobiotic in the digestive tract of these birds. Only one out of 82 serum samples collected from pigeons and Psittacine birds was positive (title 1:2) showing that Cryptococcus sp. probably has a low invasive capability in birds, and is thus considered only a dry excreta colonizer.


Author(s):  
Thilo Schub ◽  
Johannes Forster ◽  
Sebastian Suerbaum ◽  
Johannes Wagener ◽  
Karl Dichtl

AbstractInfections by the basidiomycete yeast Cryptococcus neoformans are life-threatening diseases claiming more than 600,000 lives every year. The most common manifestation is cryptococcal meningitis in AIDS patients. Diagnosis primarily relies on antigen testing from serum and cerebrospinal fluid (CSF). Current guidelines recommend rapid antigen testing with a focus on point-of-care assays. Over the recent years, a range of new lateral flow assays (LFAs) was launched. There is still a lack of data evaluating the CE-certified Biosynex RDT CryptoPS LFA. We compared the performance of this LFA with a latex agglutination assay (LAA; Latex-Cryptococcus Antigen Detection System, IMMY) from blood and CSF samples. Blood and/or CSF samples of 27 patients with proven cryptococcal infections caused by different species and blood–CSF pairs of 20 controls were tested applying LFA and LAA. Upon combined analysis of blood and CSF, both assays were able to identify all C. neoformans infections. Based on CSF analysis only, the LFA and the LAA had sensitivities of 100% and 93%. Neither test gave false-positive results nor was reactive in two cases of C. non-neoformans/non-gattii species infections. Both assays have high sensitivities and specificities for the diagnosis of C. neoformans infection. Contrarily to the IMMY LAA, the RDT CryptoPS LFA is suitable as a point-of-care test but is limited in the quantification of antigen reactivity.


2009 ◽  
Vol 1 (02) ◽  
pp. 067-068 ◽  
Author(s):  
RM Saldanha Dominic ◽  
H V Prashanth ◽  
Shalini Shenoy ◽  
Shrikala Baliga

ABSTRACT Background: Cryptococcus neoformans is the most common fungal pathogen to infect the central nervous system, and an effective diagnostic method is therefore necessary for the early diagnosis of cryptococcal meningitis. Aim: The efficacy of India ink preparation, cerebrospinal fluid (CSF) culture and CSF cryptococcal antigen detection by the latex agglutination test for diagnosis of cryptococcal meningitis are compared to determine the most efficient test. Materials and Methods: Two hundred CSF samples from human immunodeficiency virus - positive patients suspected to be suffering from meningitis were screened for Cryptococcus neoformans. Results: Latex agglutination for cryptococcal antigen detection was found to be more sensitive compared to India ink staining and CSF culture. Conclusion: Antigen detection by latex agglutination proved to be both sensitive and specific method for the diagnosis of cryptococcal meningitis. Rapid, early diagnosis of infection by detection of cryptococcal antigen by latex agglutination may alter the prognosis for these patients.


2006 ◽  
Vol 13 (7) ◽  
pp. 740-746 ◽  
Author(s):  
Ziba Jalali ◽  
Lucky Ng ◽  
Nina Singh ◽  
Liise-anne Pirofski

ABSTRACT Cryptococcosis is an important complication of solid-organ transplantation, but the risk factors for disease are poorly understood. The goal of this study was to investigate whether specific or nonspecific serum immunoglobulin levels determined in samples obtained before and after solid-organ transplantation differed in patients who did or did not develop cryptococcosis after transplantation. We analyzed pretransplantation sera from 25 subjects, 15 who subsequently developed cryptococcosis and 10 who did not, and posttransplantation sera from 24 subjects, 13 who developed cryptococcosis and 11 who did not. All subjects received a tacrolimus-based immunosuppressive regimen. Total immunoglobulin levels were measured by immunodiffusion, and Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan (GXM)-specific serum antibody levels were determined by enzyme-linked immunosorbent assays. The results showed that solid-organ transplantation had a significant effect on total immunoglobulin and GXM-reactive antibody levels. GXM-reactive antibody levels differed in subjects who did and did not develop cryptococcosis. In pretransplant serum samples, the levels of GXM-reactive immunoglobulin M (IgM) were significantly lower in subjects who developed cryptococcosis after transplantation than in those who did not. For posttransplant serum samples, the levels of GXM-reactive IgM and IgG were significantly higher among the subjects who developed cryptococcosis than among those who did not. These findings suggest that perturbations in the preexisting antibody or B-cell repertoire and/or related to treatment of rejection, transplantation, or immunosuppressive therapy could translate into an increased risk for transplant-associated cryptococcosis.


2014 ◽  
Author(s):  
Μαρία Αλεξάνδρου

TitleClinical investigation and evaluation of a serological Candida antigen detection method inearly diagnosis of systemic Candidiasis, in a tertiary hospital.IntroductionSystemic candidiasis (SC) is associated with high morbidity and mortality between theimmunocompromised patients. The early diagnosis of systemic candidiasis remainsproblematic and the timing of antifungal therapy is critical. Since the conventional diagnosticmethods lack of sensitivity and positive blood cultures take a long period turn into positive,alternative non-culture techniques have been developed.Purpose of the studyThe purpose of the study is to assess the predictive value of a serological antigen detection testfor the diagnosis of SC, using the Candida Detection Cand-Tec* latex agglutination System .Material and methodThe study was prospective and 100 patients, hospitalized in a tertiary hospital, with Proven,Probable and Possible invasive candidiasis were enrolled in; 324 serum samples werecollected in total, 131 serum samples from 39 patients with proven and probable systemiccandidiasis (group A and B) and 193 from 61 patients with possible systemic candidiasis(group C). Besides, 100 healthy controls were enrolled in the study (group D).For the purpose of the study , the classification of the patients in proven, probable or possibleSC was based on the criteria of the original definitions of systemic fungal infections of theEORTC / MSG . The isolation and the identification of the candida spp, was performed bystandard techniques and the Candida antigens were detected in serum using the CandidaDetection Cand-Tec latex agglutination System (Ramco Lab., Inc. , Houston, Texas). Theassay was performed according to the manufacturer. Antigen titers of >=1:4 were correlatedwith SC.ResultsOverall, 100 patients were collected 324 serum samples, 131 of the 39 patients in groups A (7)and B (32) and 193 of the 61 patients of group C and 102 serum samples from 100 healthycontrols (group D) .Group A, patients with Proven SC (7 ): 2 patients (29%), with negative or marginal result<= ½, 4 patients (57%) with positive titer 1:4 and 1 patient (14%) with positive titer 1:8Group B, patients with Probable SC (32 )14 patients (44%) with negative or marginal titer <= ½, 11 patients (34%) with positive titer1:4 and 7 patients (22%) with titer 1:8.Group C, patients with Possible SC (61)45 patients (74%) with negative or marginal titer <= ½, 10 patients (16%) with positive titer1:4, 5 patients (8%) with titer 1:8, and a positive titer 1:16 in 1 patient (2%).Group D (healthy controls) (100): Two serum samples with borderline positive 1:2 wereconsidered to be negative after repeated the blood tests the week that followed. Conclusions1. The method presents a moderate sensitivity (56-72%) with an average of 64% andhigh specificity of 83% (76-89%) .2. The positive predictive value of the method, for marginal titles 1:2 is low to 26%(19-33%). However, for higher titers (> = 1:4) the positive predictive valueincreases to 56% (48-64%).3. The negative predictive value of the method for all the titles is very high andamounts to 86% (80-92%).4. The probability of finding a positive antigen titer ( > = 1:4 ) increases significantlyin cases of prior abdominal surgery or when the patient had passed throughmultiple colonization.5. Out of all the patients with proven , probable and possible SC, prior chemotherapyincreases the probability of finding a positive titer antigen by four times, previousabdominal surgery by six times , while the multiple colonization further increasesthe possibility of positive results also.6. Τhe results of our study regarding the sensitivity and specificity of the method areconsistent with the international literature.7. The implementation of this serologic method in the diagnosis of SC remainslimited, due to its low sensitivity. Ηowever, due to its high negative predictivevalue, the use of the method remains helpful for the exclusion of the SC.


2000 ◽  
Vol 38 (11) ◽  
pp. 4152-4159 ◽  
Author(s):  
J. B. March ◽  
C. Gammack ◽  
R. Nicholas

Latex microspheres (diameter, 8 μm) were coated with anti-Mycoplasma capricolum subsp.capripneumoniae polyclonal immunoglobulin G (IgG) antiserum (anti-F38 biotype). The coated microspheres, when used in a latex agglutination test (LAT), detected M. capricolumsubsp. capripneumoniae antigen in the serum of goats with contagious caprine pleuropneumoniae (CCPP). Beads also agglutinated strongly in the presence of purified M. capricolumsubsp. capripneumoniae capsular polysaccharide (CPS). Preabsorption of CPS-specific antibodies prior to coating of the beads removed agglutinating activity in the presence of M. capricolum subsp. capripneumoniae, strongly suggesting that CPS is the likely soluble antigen recognized by the test. In addition, the specificity of the LAT exactly mirrored that of an M. capricolum subsp. capripneumoniaeCPS-specific monoclonal antibody (WM25): of the 8 other mycoplasma species tested, agglutination was observed only with bovine serogroup 7. The LAT detected all 11 strains of M. capricolumsubsp. capripneumoniae examined in this study, with a sensitivity level of 2 ng of CPS, or the equivalent of 1.7 × 104 CFU, in a reaction volume of 0.03 ml of serum. With field sera from goats with CCPP, the results of the LAT exhibited a 67% correlation with the results of the currently used complement fixation test (CFT), with the main discrepancy in diagnosis resulting from the increased sensitivity of the LAT compared to that of CFT. This antigen-detection LAT should prove particularly useful in identifying animals in the earliest stages of CCPP and combines sensitivity and low cost with ease of application in the field, without the need for any specialist training or equipment.


1997 ◽  
Vol 352 (1355) ◽  
pp. 763-770 ◽  
Author(s):  
D. R. Bainbridge ◽  
M. W. Lowdell ◽  
I. M. Hannet ◽  
K. W. Strauss ◽  
A. Karpas

Healthy HIV–positive regular donors of plasma in a programme of passive immunotherapy for AIDS patients were studied over a period of about two years. None developed symptoms of clinical progression; most seemed to make substantial gains of CD4 cells by comparison with asymptomatic individuals who were not donating. The effects of donation did not seem to diminish with repetition, and donor CD4 counts tended towards stabilizing within normal limits. Asymptomatic HIV–positive individuals were compared immunologically with ‘normals’ and people with AIDS, using a battery of 25 measurements on peripheral blood. The immunological profiles of donor and non–donor asymptomatics, indistinguishable at the start, became dissimilar: donors' profiles resembled AIDS less, non–donors became less like ‘normal’ and a few non–donor results could not be distinguished from AIDS. Improvement in the CD4 counts and amelioration of the immunological profile in donors provide prima facie evidence that plasmapheresis may be therapeutic for asymptomatic HIV–positive people. Further studies are justified.


2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Dezhi Feng ◽  
Jing Su ◽  
Yi Xu ◽  
Guifang He ◽  
Chenguang Wang ◽  
...  

AbstractProstate-specific antigen (PSA) is the most widely used biomarker for the early diagnosis of prostate cancer. Existing methods for PSA detection are burdened with some limitations and require improvement. Herein, we developed a novel microfluidic–electrochemical (μFEC) detection system for PSA detection. First, we constructed an electrochemical biosensor based on screen-printed electrodes (SPEs) with modification of gold nanoflowers (Au NFs) and DNA tetrahedron structural probes (TSPs), which showed great detection performance. Second, we fabricated microfluidic chips by DNA TSP-Au NF-modified SPEs and a PDMS layer with designed dense meandering microchannels. Finally, the μFEC detection system was achieved based on microfluidic chips integrated with the liquid automatic conveying unit and electrochemical detection platform. The μFEC system we developed acquired great detection performance for PSA detection in PBS solution. For PSA assays in spiked serum samples of the μFEC system, we obtained a linear dynamic range of 1–100 ng/mL with a limit of detection of 0.2 ng/mL and a total reaction time <25 min. Real serum samples of prostate cancer patients presented a strong correlation between the “gold-standard” chemiluminescence assays and the μFEC system. In terms of operation procedure, cost, and reaction time, our method was superior to the current methods for PSA detection and shows great potential for practical clinical application in the future.


Sign in / Sign up

Export Citation Format

Share Document